InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,566.71
(
1.12%
)
US TECH 100
19,315.28
(
1.61%
)
Dow Jones
40,373.42
(
0.21%
)
Brent Oil
81.58
(
-0.86%
)
Bitcoin
67,467.45
(
-1.01%
)
Post# of 47295
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

tsuguy

Send PM Follow Ignore
Followers 22
Posts 513
Boards Moderated 0
Alias Born 03/24/2005

tsuguy

Re: None

Wednesday, 12/24/2014 7:12:33 AM

Wednesday, December 24, 2014 7:12:33 AM

Post# of 47295
AMBS back to breakout point. Larger volume yesterday may give this the momentum for breakout. Chart is set to run, let's see if it does it this time.

This has had lots of great news for biotech stock over the last two days and you know how quick biotech stock can move.

Amarantus Receives Orphan Drug Designation for MANF in Retinitis Pigmentosa http://bionapcfa.blogspot.com/2014/12/amarantus-receives-orphan-drug.html?m=1

Low, how would you evaluate this one with the latest FDA approval news and the news of first Alzheimer's blood test launched for use in clinical trials.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up